FCGRT and allergic disease: In humans, allergen-specific IgE can cross the placenta through IgE-IgG complexes with FcRn, can bind IgE-receptors on fetal mast cells, and has the potential to enable early allergen responses in infants, increase the allergic environment, and increase the risk of allergy development (60).